FIGURE 3.

Serum lipid mediator concentrations are altered in patients with atherosclerosis versus healthy controls. Serum was collected from healthy volunteers (n = 6) and patients with cardiovascular disease (n = 6). Lipid mediators were extracted, identified and quantified using LC‐MS/MS‐based lipid mediator profiling (See methods for details). (A) Differences in lipid mediator concentrations were evaluated using PLS‐DA two‐dimensional scores plot, and (B) corresponding VIP plot of serum lipid mediators. Shaded areas represent 95% confidence interval